Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 April, 2018 18:35 IST
Zydus Cadila receives approval from USFDA for Fingolimod capsules
Source: IRIS | 17 Jul, 2017, 08.30AM
Comments  |  Post Comment

Zydus Cadila has received the tentative approval from the USFDA to market Fingolimod Capsules, 0.5 mg. The drug is an immunomodulating drug, mostly used for treating multiple sclerosis  and will be produced at the group’s formulations manufacturing facility at the Pharma SEZ, in Ahmedabad.

The sales of Fingolimod Capsules is estimated at USD 2.1 billionn. Source: IMS Health, IMS National Sales Perspective Audit, MAT May 2017, extracted July 2017.
 
The group now has more than 120 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.  

Shares of the company gained Rs 13.9, or 2.68%, to settle at Rs 532.50. The total volume of shares traded was 152,487 at the BSE (Friday).





Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Welspun Corp bags contract to supply water pipes in MENA region - 20-Apr-2018 10:17
TVS Motor Company launches TVS XL100 Heavy Duty 'i-Touch Start' - 20-Apr-2018 10:14
Yes Bank receives RBI approval to open overseas offices - 20-Apr-2018 10:07
Glenmark Pharma gets final nod for Clobetasol Propionate solution - 20-Apr-2018 10:03
TCS Q4 earnings grow 5.7% sequentially to Rs 69.04 bn - 20-Apr-2018 10:00
Prism Cement is now Prism Johnson - 19-Apr-2018 15:51
NACL Ind enters into strategic alliance with BioWorks - 19-Apr-2018 15:25
Ramco Systems partners with L3 MAS - 19-Apr-2018 15:21
MCX inks pact with Northern India Textiles Mills' Association - 19-Apr-2018 15:16
BP and Reliance sanction second phase of integrated KG D6 development - 19-Apr-2018 13:45
IndusInd Bank Q4 profit grows 27% to Rs 9.53 bn - 19-Apr-2018 13:40
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer